On Wednesday, October 6 at 1 pm EST the Crohn's & Colitis Foundation of America will host an educational program on emerging advances in Crohn's disease treatments for patients, family members and caregivers living with Crohn's disease, a chronic and often debilitating digestive disease affecting over 700,000 Americans. This interactive webcast/ teleconference, Progress in CD: An Update On the Advances In Crohn's Disease, which is supported by an educational grant from Centocor Ortho Biotech Inc, is now open for registration at www.ccfa.org/webcasts/CrohnsUpdate.
The program will be led by Dr. Jonathan Braun, M.D., Ph.D., Professor of Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology, at the David Geffen School of Medicine at UCLA. He will discuss the emerging advances and progress in treating and understanding Crohn's disease and answer audience questions during an interactive question-and-answer session.
"New discoveries and therapies for Crohn's disease are emerging and through the Crohn's disease update event on October 6, patients nationwide can tune in and hear more about recent discoveries and the latest treatments," explains Dr. Braun. "I highly encourage all Crohn's patients and their caregivers nationwide to take advantage of this opportunity and tune in to the event."
This educational event is available at no cost to participants. It will answer important questions about Crohn's disease, including:
• What are the current and emerging therapies for Crohn's disease?
• How is research targeting and utilizing genetics?
• What is new in pediatric research?